confluent areas of hypocellular collagen deposition with preservation and thickening of the alveolar septal elastic framework, associated with pleural fibrosis. 2 This appearance is quite distinct from other fibrotic lung diseases such as usual interstitial pneumonia and pulmonary infarction. Clinically, there is overlap between the two phenotypes whereby patients with BOS can also have findings of PF on lung histology; conversely, patients with RAS usually have concomitant OB in addition to extensive PF. 2, 4 The prevalence and significance of this overlap are not well understood. Other pathologic findings can coexist with OB or PF, such as vascular fibrosis 2 and bronchial epithelial damage. 7 Animal models are key for the advancement of our mechanistic understanding of CLAD pathogenesis. Simpler models of tracheal transplantation focus on development of AF pathology and are criticized for not recapitulating the entire pulmonary structural and immune milieu. The orthotopic mouse single lung transplantation model has been established as the most physiologic model of lung allograft rejection, 8 now allowing assessment of fibrotic pathology of not only the airways, but also the parenchyma and vasculature, which have not been sufficiently described in prior studies.
Transplantation of C57BL/10 donor lungs to C57BL/6 recipients (minor-mismatched strains), without the use of immunosuppression, has been reported to yield airway obliteration in approximately 50%
of allografts 3 to 4 weeks after transplantation, in association with moderate to severe acute rejection. 9 This model of OB has been used in several studies focusing on the pro-fibrotic role of IL-17. (H2 d ) 17 have shown OB in the grafts.
In most mouse studies of chronic lung allograft fibrosis, the main endpoint has been the presence or absence of OB or nonobliterative AF. We postulate that OB exhibits a spectrum of severity from mild to severe rather than simply being present or absent, and that it may coexist with other features of human CLAD-like pathology such as PF, pleural fibrosis, vascular fibrosis, and bronchial epithelial changes. We therefore aimed to detail and also quantify a wide range of pathologic features of CLAD in this model, using a minor-alloantigen-mismatched strain combination and its reverse.
The parameters defined in this manuscript can serve as useful endpoints for further mechanistic studies of CLAD.
| MATERIAL S AND ME THODS

| Animal procedures
Animals received care in compliance with the Guide to the Care and Use of Experimental Animals. Eight to 12-week-old male C57BL/6J (B6) and C57B/10J (B10) mice (Jackson Laboratory, Bar
Harbor, ME) were maintained in a pathogen-free environment on a standard diet. Donor left lungs were transplanted orthotopically into recipients following the technique previously described by 
| Histology
Paraffin-embedded lung graft samples were sectioned for pathologic assessment (5 μm) and stained with Hematoxylin & Eosin (H&E), Masson-Trichrome, and Elastic-Trichrome stains.
| Grading of rejection, airway obliteration, and lung parenchymal fibrosis
Acute cellular rejection was graded utilizing International Society for
Heart and Lung Transplantation criteria. 18 The other grading parameters were developed by T.M. and D.H. (Table 1) . Grading was performed by T.M. blinded to group assignment. Data were reproduced via independent blinded grading by G.B.
Airway fibrosis: For each lung sample, all visible airways were evaluated on Masson-Trichrome-stained slides. Each airway was given a peri-airway fibrosis (P-AF) score from 0 to 4, 0 being no fibrosis, 1-4 reflecting fibrosis thickness equivalent to 1 to 4 mononuclear cells.
Airway obliteration:
The percentage of obliterated airways was calculated. Obliterated airways were graded: 1 = 1-25%, 2 = 26-50%, 3 = 51-75%, 4 = 76-100% obliteration.
Parenchymal fibrosis (PF) grading:
The percentage of the lung area affected by PF was estimated using Masson-Trichrome and Elastic-Trichrome-stains.
Additional features were graded semi-quantitatively from 0 to 4: 0 = none, 1 = minimal, 2 = mild, 3 = moderate, 4 = severe using
Masson-Trichrome-stained slides (pleural fibrosis), Elastic-Trichromestained slides (vascular fibrosis), and H&E-stained slides (lymphoid aggregates, endothelialitis, epithelial hyperplasia, and epithelial flattening). Presence of eosinophils, neutrophils, and foamy macrophages was assessed (see supplement). 
| Statistical analysis
| RE SULTS
| Spectrum of airway disease
Twenty-eight days after lung transplantation, syngeneic (B6→B6) and allogeneic (B10→B6) lung grafts were assessed for the pres- (mean scores of 1.8 and 2, respectively) ( Figure 2I ).
| Parenchymal and pleural fibrosis
Severely affected allografts showed diffuse, extensive PF 
| Acute rejection and inflammation
Acute cellular rejection A-grades and airway inflammation Bgrades 18 were highest in B10→B6 grafts at day 28, with no significant acute rejection in syngeneic grafts (Figures 5A,B and 6A-C).
Lymphoid aggregates or follicles were frequently seen within the lung allografts, most prominent in fibrotic B10→B6 allografts at day 28, and not seen in syngrafts ( Figures 1D, 5C , and 6E-F).
There were no noticeable eosinophils within the lung sections.
Neutrophils or foamy macrophages were rare at days 5 through 7 and 28; a trend towards higher prevalence of neutrophils and foamy macrophages was seen at day 14 ( Figure S1 ), especially in areas of early PF. There was a weak but significant correlation be- Figure 7D ). 28 allografts, epithelial hyperplasia correlated more strongly with P-AF, while epithelial flattening had a stronger correlation with airway obliteration, although all correlation coefficients were quite weak ( Figure 8C ). 
| B6→B10 strain combination
| D ISCUSS I ON
In this study we reviewed the spectrum of chronic lung allograft pathology in a minor-mismatched orthotopic lung transplant model at multiple time-points and developed an easy-to-use scoring system for each histologic finding (Table 1) .
F I G U R E 4
Grading of parenchymal and pleural fibrosis. B6 mice received left lung allografts from B6 (Syn) or B10 (Allo) donors and were sacrificed 5-7 (n = 3Syn, 8Allo), 14 (n = 3Syn, 10Allo), or 28 (n = 5Syn, 9Allo) days after transplant. An additional group of B10 mice received left lung grafts from B6 donors and were sacrificed 28 days after transplant (n = 7). (A) The percent of the lung area affected by parenchymal fibrosis was estimated. Highest parenchymal fibrosis scores were seen in B10→B6 mice 14 and 28 days posttransplant. (B-D) For the B10→B6 Allo group sacrificed 28 days after transplant, correlation between airway and parenchymal fibrosis was evaluated. While the correlation coefficients (R) are modest, correlations were significant between airway obliteration and parenchymal fibrosis. (E) The severity of pleural fibrosis was graded on a scale of 0 to 4. Pleural fibrosis was seen in all the Allo groups, but highest scores were identified in the B10→B6 mice 14 and 28 days posttransplant. (F) For the B10→B6 Allo group sacrificed 28 days after transplant, correlation between pleural and parenchymal fibrosis was assessed and was found to be significant. (A,E) Mann-Whitney U test was used for comparisons; *P < .05. The minor-mismatched orthotopic mouse lung transplantation using B10 donors and B6 recipients was first reported as a model of OB with obliterative airway lesions found in about 50% of allografts 3 to 4 weeks posttransplant. 9 In our study, four of nine (44%) mice at day 28 had prominent fibrotic obliteration (affecting >70% of allograft airways). However, two of the other five mice had smaller numbers of lesions (<15% of airways obliterated) with relatively normal lung tissue in other areas. We have confirmed similar rates in other separate experiments. This observation is reminiscent of OB in human lung allografts, where this pathology is patchy and can spare large areas of the lung. OB in human lung transplant recipients is most often of the constrictive type with regular circumferential submucosal collagen deposition. However, proliferative OB lesions, characterized by polypoid intra-airway fibrotic lesions, are also seen in human lung allografts. We propose that the obliterative airway fibrosis (O-AF) that we described is the mouse allograft equivalent of human proliferative OB. We also observed collagen deposition around airways, herein termed peri-airway fibrosis (P-AF). Blinded grading showed greater P-AF in allografts compared with syngrafts, suggesting that an overall increase in collagen deposition is associated with the alloimmune process, irrespective of the presence or degree of O-AF or OB.
In addition to AF, we found that minor-mismatched allografts exhibited the particular pattern of PF called pleuroparenchymal fibroelastosis, which has been described in patients with RAS. 2 As pointed out in an editorial by Vanaudenaerde et al., 19 prior studies of B10→B6 orthotopic lung transplantation showed RAS-like PF in histology images without specific description or quantification thereof. 9, 10, 12, 20 We have also noted the presence of PF in our prior study; 11 However, to our knowledge, this is the first detailed analysis of this pattern in mouse lung allografts and the first demonstration of its resemblance to the human RAS phenotype.
We further showed a correlation between AF and PF. However, this correlation was relatively weak with examples of allografts that had a high percentage of obliterated airways and only minimal to moderate PF. These allografts are reminiscent of pathology of human BOS patients with a primarily obstructive pattern and minimal restriction. Conversely, severe PF was usually seen in the context of concurrent airway obliteration; this observation is also very similar to lung allograft pathology in patients with RAS, who typically have OB in association with pleuroparenchymal fibroelastosis.
The acute rejection pathology in our mouse allografts likewise resembled human lung acute rejection. Furthermore, lymphoid F I G U R E 6 Acute rejection and inflammation. B6 mice received left lung allografts from B6 (Syn) or B10 (Allo) donors and were sacrificed 5-7 (n = 3Syn, 8Allo), 14 (n = 3Syn, 10Allo), or 28 (n = 5Syn, 9Allo) days after transplant. An additional group of B10 mice received left lung grafts from B6 donors and were sacrificed 28 days after transplant (n = 7). 
B10->B6
Syn aggregates were seen in the mouse allografts, similar to tertiary lymphoid organs that have been described previously in the context of animal rejection models and human CLAD. 21, 22 A significant correlation was seen between A-grade rejection and lymphoid aggregates and PF, supporting the implication of the alloimmune process in the pathogenesis of allograft fibrosis.
Endothelialitis and vascular fibrosis are often seen in lung allografts from CLAD patients. 2 To our knowledge, these findings have not been described in mouse lung allografts. In this study, we observed and graded endothelialitis, which occurred in allografts but not in syngrafts. Vascular fibrosis was very prominent in severely fibrotic allografts and correlated with the severity of both airway and parenchymal fibrosis.
Epithelial damage is thought to represent part of a final common pathway in OB pathogenesis. Airway epithelial hyperplasia and flattening were seen prominently in our mouse lung allografts but the correlation between these changes and fibrosis was weak. We postulate that this may be due to the fact that epithelial damage happens at earlier time-points, prior to development of later fibrosis.
While this minor-alloantigen-mismatched orthotopic lung transplant model appears to show features of human CLAD pathology, we acknowledge that it has a number of limitations. The O-AF lesions are proliferative while OB in humans is mostly of the constrictive type.
Furthermore, while the allograft pathology has strong similarities to that seen in human CLAD, lung function is difficult to study in this model since only one lung is transplanted. Most importantly, the incidence of O-AF and severe PF remained around 50%. While this is similar to the human scenario, this nonhomogeneous phenotype renders studies of this mouse model more cumbersome, requiring higher numbers of mice in each group. Notably, while the B6→B10 strain reversal allows the use of genetically engineered mice on C57BL/6 background as either donors or recipients, we show that there is a trend toward reduced inflammation and fibrosis in this setting, emphasizing the importance of strain variation. Additionally, the incidence of O-AF pathology in the B10→B6 minor-mismatched strain combination has been reported to be much lower, or even nonexistent, with only P-AF development, in some experiments (personal communication and references 16, 23 ). This reported fibrosis variability may be due to slight strain variations (eg, C57BL/6J vs. C57BL/6N), 24 different housing environments, and technical or surgical factors. Further manipulations of this strain combination to diminish or augment alloimmunity, inflammation and/or fibrosis will be important to better understand the determinants of PF, O-AF, and P-AF development. Additionally, the availability of other strain combinations to study the pathology associated with CLAD is expanding the armamentarium for CLAD research. 15, 17 In summary, the C57BL/10-to-C57BL/6 (and the reverse) 
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